Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
South · North Carolina
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Raleigh (480,000 residents, 1,500,000 metro). Research Triangle region overlaps with Duke and UNC academic systems; NC Medicaid expansion launched December 2023.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Raleigh →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Raleigh →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Raleigh →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Raleigh →
Raleigh is a south-region city with a population of 480,000 (1,500,000 in the broader metropolitan area). North Carolina expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Duke Health, UNC Health, Atrium Health, Novant Health.
North Carolina's Medicaid program is NC Medicaid. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.